J. C. Barrera

39th ESCP European symposium on clinical pharmacy & 13th SFPC congress: clinical pharmacy at the front line of innovations. 21–23 October 2010, Lyon, France

C. D. Fajardo, M. P. Ortega, J. C. Barrera, 2011, International Journal of Clinical Pharmacy.

Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine

J. C. Barrera, X. Díaz-Villamarín, C. Dávila-Fajardo, 2019, Genes.

Mitomicina C tópica endotraqueal como terapia complementaria al tratamiento endoscópico de la estenosis laringotraqueal fibrótico-cicatricial recurrente

J. C. Barrera, M. Medina, A. Salmerón-García, 2011 .

Topical endotracheal mitomycin C as a complementary treatment for endoscopic treatment of recurrent laryngotracheal stenosis

J. C. Barrera, M. Medina, A. Salmerón-García, 2011 .

IL2/IL21 region polymorphism influences response to rituximab in systemic lupus erythematosus patients

Cristina Lucía Dávila-Fajardo, Javier Martín, G. Robledo, 2013, Molecular Biology Reports.

CP-118 Utilisation study of antidiabetic drugs 2001–2014 and hospitalisations due to diabetes complications

J. C. Barrera, Jm Martínez, M. Lirola, 2016 .

The study protocol for a non-randomized controlled clinical trial using a genotype-guided strategy in a dataset of patients who undergone percutaneous coronary intervention with stent

J. C. Barrera, C. Dávila-Fajardo, L. J. Martínez-González, 2016, Data in brief.

IL2/IL21 region polymorphism influences response to rituximab in systemic lupus erythematosus patients

Javier Martín, G. Robledo, R. Ríos-Fernandez, 2013, Molecular Biology Reports.